Viruses and Human Disease

By Naeem Mustafa, Registered Pharmacist & Founder, PharmaServePk | Serving Health, Serving Lives  Update Knowledge

Viruses are among the smallest infectious agents known to science, yet they are responsible for some of humanity's most significant health burdens — from the common cold to hepatitis, dengue, and certain cancers. Understanding how viruses interact with the human body helps patients make better decisions about prevention, vaccination, and when to seek treatment. This guide breaks down the biology in plain language and looks specifically at how viral disease Effects .

pharmaservepk

What Makes a Virus Different From Bacteria?

Unlike bacteria, viruses cannot reproduce on their own. They are essentially genetic material — DNA or RNA — wrapped in a protein shell, and they depend entirely on invading a living cell to make copies of themselves. This is why antibiotics, which target bacterial cell structures, have no effect on viral infections. It's a distinction pharmacists explain to patients daily, especially when someone requests antibiotics for a cold or flu.

How Viruses Actually Cause Disease

Once inside the body, viruses can harm us through several distinct mechanisms:

• Direct cell damage: The virus hijacks a cell's machinery to replicate, eventually destroying the cell. Influenza, for example, damages the lining of the respiratory tract this way.
• Immune overreaction: Sometimes it isn't the virus itself but the body's own inflammatory response that causes the most harm. This was seen dramatically in severe COVID-19 cases, where an overactive immune response ("cytokine storm") damaged the lungs.
• Long-term cell transformation: Certain viruses can alter a host cell's DNA over time, increasing cancer risk. Persistent HPV infection is linked to cervical cancer, while chronic hepatitis B and C infection are major drivers of liver cancer worldwide.
• Latency and reactivation: Some viruses, like the herpes family, don't fully leave the body after the initial infection. They lie dormant in nerve cells and can reactivate later — the chickenpox virus reactivating as shingles decades afterward is a well-known example.

Pakistan's Viral Hepatitis Burden: Why It Matters

Globally, viral hepatitis has become one of the deadliest infectious diseases. According to WHO's 2024 Global Hepatitis Report, viral hepatitis is now the second leading infectious cause of death worldwide, claiming roughly 1.3 million lives a year — a toll on par with tuberculosis. Globally, an estimated 254 million people live with hepatitis B and 50 million with hepatitis C, and deaths from viral hepatitis rose from 1.1 million in 2019 to 1.3 million in 2022, with hepatitis B responsible for about 83% of these deaths and hepatitis C for the remaining 17%. Pakistan is one of the countries most affected by this global trend. WHO's report notes that Pakistan is among ten countries — alongside Bangladesh, China, Ethiopia, India, Indonesia, Nigeria, the Philippines, Russia, and Vietnam — that together account for nearly two-thirds of the world's hepatitis B and C burden. National data paint a sobering picture: hepatitis B affects roughly 1.6% of Pakistan's general population, causing about 12,000 deaths a year, while hepatitis C affects around 7.5% of the population, with about 545,000 new infections and 19,000 deaths annually. Research into risk factors has consistently pointed to preventable causes. A large sero-survey in Sindh province found that HCV exposure was strongly associated with prior blood transfusion, a family history of hepatitis, receiving medical injections in the past year, tattooing, and shaving at traditional barber shops, with the same study estimating that unsafe medical injections alone accounted for roughly 38% of HCV exposure cases. This underscores a message pharmacists in Pakistan repeat often: unsafe injection practices and unscreened blood products remain major, preventable drivers of hepatitis transmission.

How Viral Diseases Are Treated

Unlike bacterial infections, most viral illnesses don't have a single "magic bullet" cure. Management generally falls into a few categories:

• Antiviral medicines: These target specific steps in a virus's life cycle — for example, neuraminidase inhibitors for influenza, nucleos(t)ide analogs for hepatitis B, and direct-acting antivirals (DAAs) that have transformed hepatitis C from a chronic disease into a curable one for most patients.
• Vaccination: Still the single most powerful public health tool against viral disease. Hepatitis B vaccination, in particular, has dramatically reduced new infections in countries with strong birth-dose coverage.
• Supportive care: For many common viral infections — most colds, flu, and dengue — there's no specific cure. Treatment focuses on rest, hydration, fever and symptom control, and watching for warning signs of complications.
• Passive immunity: Immunoglobulins or monoclonal antibodies are used in specific high-risk situations, such as rabies post-exposure prophylaxis after an animal bite.

Practical Prevention Tips

• Complete recommended vaccinations, especially hepatitis B, which is part of Pakistan's routine immunization schedule.
• Insist on new, single-use needles and syringes for any injection or medical procedure.
• Avoid unnecessary injections — many conditions treated with an injection could be managed with oral medicines just as effectively.
• Ensure blood transfusions come from properly screened sources.
• Use barber and tattoo services that follow proper sterilization practices, or bring your own disposable blades.
• Practice regular handwashing and safe food/water hygiene to reduce gastrointestinal viral infections.
• Use mosquito control measures (repellents, nets, eliminating standing water) to reduce dengue risk during monsoon season.

Key Takeaway

Viruses cause disease through direct cell damage, immune overreaction, long-term cellular changes, or dormant reactivation — and the health impact ranges from a mild cold to life-threatening liver disease. For Pakistan specifically, hepatitis B and C represent a large and largely preventable disease burden, closely tied to unsafe injection practices. Vaccination, safe medical practices, and early screening remain the most effective tools available to reduce this burden.

---

References

1. World Health Organization. Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries. WHO, April 2024. Available at: who.int/publications/i/item/9789240091672
2. World Health Organization Global Hepatitis Programme. "WHO Sounds Alarm on Viral Hepatitis Infections Claiming 3500 Lives Each Day." News release, 9 April 2024. Available at: who.int
3. Chaudhry, S. et al. "Barriers and Strategies for Hepatitis B and C Elimination in Pakistan." The Journal of Infectious Diseases, Oxford Academic, 2023.
4. Butt, S. et al. "Changes in the Prevalence of Hepatitis B and C Viral Infections in Sindh Province, Pakistan: Findings from Two Sero-Surveys in 2007 and 2019." Journal of Viral Hepatitis, 2024;31:645-656.
5. National Center for Biotechnology Information (NCBI/PMC). "Global Hepatitis Elimination 2030: Immediate Action is the Need of the Hour." PMC11490652, 2024.

---

About the Author: Naeem Mustafa is a pharmacist with over 25 years of experience in pharmaceutical sales, marketing, and health education in Pakistan. He is the founder of PharmaServePk, a pharmacist-reviewed platform dedicated to accurate, accessible health information for the public.

Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare provider for diagnosis and treatment.